FAKTOR-OPTIONSSCHEIN - QUEST DIAGNOSTICS | Real-time Bid/Ask 05:42:35 2024-06-04 EDT | ||
| 8.44 EUR / 8.56 EUR | +2.29% |
|
| Current month | -3.93% | ||
| 1 month | -14.33% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 24-06-03 | 8.31 | -3.93% |
| 24-05-31 | 8.65 | -1.82% |
| 24-05-30 | 8.81 | -2.65% |
| 24-05-29 | 9.05 | +2.26% |
| 24-05-28 | 8.85 | +7.53% |
Delayed Quote Börse Stuttgart
Last update June 03, 2024 at 03:47 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Morgan Stanley |
| WKN | MG34Y7 |
| ISIN | DE000MG34Y75 |
| Date issued | 2024-04-26 |
| Strike | 176.4 $ |
| Maturity | Unlimited |
| Parity | 3.92 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.61 € |
|---|---|
| Lowest since issue | 7.47 € |
| Spread | 0.12 € |
| Spread % | 1.40% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
141.1
USD
Average target price
147
USD
Spread / Average Target
+4.17%
- Stock Market
- Certificates
- Certificat
